Keyword: Intermountain Medical Center Heart Institute
The week’s biotech discoveries included eight mutations that contribute to cardiomyopathy and an enzyme that promotes basal-like breast cancer.
When it comes to predicting who’s at risk of suffering a heart attack or other major cardiac event, physicians have long relied on detecting high levels of C-reactive protein, but it may not be the only game in town.
Intermountain Healthcare is back at it, this time tackling Type 2 diabetes. The company has partnered with the American Medical Association and Omada Health to reduce the number of adults developing the condition.